172 related articles for article (PubMed ID: 17244226)
41. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Yazdani S; Hendi K; Pakravan M
J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
[TBL] [Abstract][Full Text] [Related]
42. Metrorrhagia after intravitreal injection of bevacizumab.
Rodrigues EB; Shiroma H; Meyer CH; Maia M; Farah ME
Acta Ophthalmol Scand; 2007 Dec; 85(8):915-6. PubMed ID: 17645422
[No Abstract] [Full Text] [Related]
43. Case of anterior uveitis after intravitreal injection of bevacizumab.
Pieramici DJ; Avery RL; Castellarin AA; Nasir MA; Rabena M
Retina; 2006 Sep; 26(7):841-2. PubMed ID: 16963867
[No Abstract] [Full Text] [Related]
44. Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ).
Algvere PV; Von Wendt G; Gudmundsson J; Seregard S; Kvanta A
Acta Ophthalmol; 2010 Dec; 88(8):836-41. PubMed ID: 19900206
[TBL] [Abstract][Full Text] [Related]
45. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.
Hoang QV; Mendonca LS; Della Torre KE; Jung JJ; Tsuang AJ; Freund KB
Ophthalmology; 2012 Feb; 119(2):321-6. PubMed ID: 22054994
[TBL] [Abstract][Full Text] [Related]
46. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.
Pai SA; Shetty R
Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250
[No Abstract] [Full Text] [Related]
47. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
[TBL] [Abstract][Full Text] [Related]
48. Coats' disease: treatment with intravitreal bevacizumab and laser photocoagulation.
Stergiou PK; Symeonidis C; Dimitrakos SA
Acta Ophthalmol; 2009 Sep; 87(6):687-8. PubMed ID: 18976310
[No Abstract] [Full Text] [Related]
49. Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.
Fang X; Sakaguchi H; Gomi F; Oshima Y; Sawa M; Tsujikawa M; Ikuno Y; Kamei M; Kusaka S; Tano Y
Acta Ophthalmol; 2008 Nov; 86(7):800-5. PubMed ID: 18547274
[TBL] [Abstract][Full Text] [Related]
50. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections.
Charles S; Rosenfeld PJ; Gayer S
Retina; 2007 Sep; 27(7):813-5. PubMed ID: 17891002
[No Abstract] [Full Text] [Related]
51. Vitreous web after pars plana vitrectomy and bevacizumab with fluid-air exchange.
Chiang A; Reddy S; Tsui I; Hubschman JP
Semin Ophthalmol; 2011 Jan; 26(1):25-7. PubMed ID: 21275601
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy.
Lima LH; Zweifel SA; Engelbert M; Sorenson JA; Slakter JS; Cooney MJ; Klancnik JM; Yannuzzi LA; Freund KB
Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815
[TBL] [Abstract][Full Text] [Related]
53. Severe intraocular pressure fluctuation after intravitreal anti-vascular endothelial growth factor injection.
Martel JN; Han Y; Lin SC
Ophthalmic Surg Lasers Imaging; 2011 Oct; 42 Online():e100-2. PubMed ID: 21986163
[TBL] [Abstract][Full Text] [Related]
54. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations].
Małgorzata F
Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123
[TBL] [Abstract][Full Text] [Related]
55. Combined intravitreal bevacizumab and argon laser treatment for Coats' disease.
Cackett P; Wong D; Cheung CM
Acta Ophthalmol; 2010 Mar; 88(2):e48-9. PubMed ID: 19500078
[No Abstract] [Full Text] [Related]
56. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
57. Large subretinal haemorrhage following change from intravitreal bevacizumab to ranibizumab.
Karagiannis DA; Mitropoulos P; Ladas ID
Ophthalmologica; 2009; 223(4):279-82. PubMed ID: 19390227
[TBL] [Abstract][Full Text] [Related]
58. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes.
Sakurai K; Akiyama H; Shimoda Y; Yoshida I; Kurabayashi M; Kishi S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4905-16. PubMed ID: 19407010
[TBL] [Abstract][Full Text] [Related]
59. Intravitreal injection of bevacizumab to treat neovascular glaucoma.
Kubota T; Aoki R; Harada Y; Tou N; Tawara A
Jpn J Ophthalmol; 2008; 52(5):410-412. PubMed ID: 18991046
[No Abstract] [Full Text] [Related]
60. Bevacizumab (Avastin) for the treatment of ocular disease.
Gunther JB; Altaweel MM
Surv Ophthalmol; 2009; 54(3):372-400. PubMed ID: 19422965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
